Aeterna Zentaris (AEZS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AEZS | BMY | AMGN | GILD | REGN |
| Company | Aeterna Zentaris | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 5.51 | 56.46 | 328.70 | 123.80 | 749.09 |
| High | 6.20 | 56.56 | 333.03 | 125.12 | 749.09 |
| Low | 5.48 | 55.10 | 326.90 | 122.10 | 726.43 |
| Latest | 5.72 | 55.26 | 330.41 | 124.91 | 733.04 |
| Change | +0.32 | -1.36 | +0.38 | +3.65 | -8.88 |
| % Change | +5.93% | -2.40% | +0.12% | +3.01% | -1.20% |
| Volume | 7,500 | 13,702,800 | 4,033,800 | 10,639,000 | 1,682,500 |
| 20-Day Average Volume | 5,065 | 14,318,740 | 2,749,175 | 6,405,805 | 883,075 |
| Previous Close | 5.40 | 56.62 | 330.03 | 121.26 | 741.92 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.81 | 54.90 | 329.14 | 122.91 | 772.91 |
| 20-Day Raw Stochastic | 27.54% | 64.26% | 49.11% | 76.26% | 6.98% |
| 20-Day Relative Strength | 47.44 | 59.07 | 52.74 | 53.81 | 47.04 |
| Weighted Alpha | -48.68 | +6.63 | +22.07 | +32.21 | +17.51 |
| Today's Opinion | 100% Sell | 100% Buy | 64% Buy | 72% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 100% Buy | 80% Buy | 40% Buy | 80% Buy |
| Last Month's Opinion | 100% Sell | 72% Buy | 72% Buy | 56% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.27% since 08/01/24 | -1.07% since 01/09/26 | +1.32% since 01/09/26 | +3.15% since 01/09/26 | -7.97% since 01/09/26 |
| Low | 5.07 on 08/05/24 | 55.10 on 01/16/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 726.43 on 01/16/26 |
| High | 6.20 on 08/08/24 | 57.04 on 01/14/26 | 333.03 on 01/16/26 | 125.12 on 01/16/26 | 811.09 on 01/12/26 |
| 1-Month | |||||
| %Chg | +8.95% since 07/08/24 | +1.90% since 12/16/25 | +1.12% since 12/16/25 | +5.16% since 12/16/25 | -1.78% since 12/16/25 |
| Low | 5.07 on 08/05/24 | 52.06 on 01/05/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 726.43 on 01/16/26 |
| High | 7.54 on 07/09/24 | 57.04 on 01/14/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 821.11 on 01/09/26 |
| 3-Month | |||||
| %Chg | -26.67% since 05/08/24 | +27.36% since 10/16/25 | +11.70% since 10/16/25 | +5.99% since 10/16/25 | +28.79% since 10/16/25 |
| Low | 3.96 on 06/21/24 | 42.52 on 10/29/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 566.11 on 10/17/25 |
| High | 11.10 on 05/29/24 | 57.04 on 01/14/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| 6-Month | |||||
| %Chg | -15.63% since 02/08/24 | +17.15% since 07/16/25 | +10.50% since 07/16/25 | +13.71% since 07/16/25 | +33.78% since 07/16/25 |
| Low | 3.96 on 06/21/24 | 42.52 on 10/29/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 541.00 on 10/13/25 |
| High | 11.10 on 05/29/24 | 57.04 on 01/14/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 821.11 on 01/09/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,256 | 112,495,712 | 177,919,520 | 154,973,344 | 77,041,760 |
| Shares Outstanding, K | 1,793 | 2,035,753 | 538,481 | 1,240,680 | 105,099 |
| Annual Sales | 4,500,000 | 48,300,000,000 | 33,424,000,000 | 28,754,000,000 | 14,202,000,000 |
| Annual Net Income | -16,550,000 | -8,948,000,000 | 4,090,000,000 | 480,000,000 | 4,412,600,000 |
| Last Quarter Sales | 120,000 | 12,222,000,000 | 9,557,000,000 | 7,769,000,000 | 3,754,300,000 |
| Last Quarter Net Income | -5,630,000 | 2,201,000,000 | 3,216,000,000 | 3,052,000,000 | 1,460,000,000 |
| 60-Month Beta | 1.55 | 0.29 | 0.45 | 0.33 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.74 on 05/14/24 | 1.63 on 10/30/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 11.83 on 10/28/25 |
| Latest Earnings Date | 08/14/24 | 02/05/26 | 02/03/26 | 02/10/26 | 01/30/26 |
| Most Recent Dividend | N/A | 0.630 on 01/02/26 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.880 on 11/20/25 |
| Next Ex-Dividends Date | N/A | 01/02/26 | 02/13/26 | 12/15/25 | 11/20/25 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 8.63 | 15.09 | 14.81 | 20.23 |